Tag: Healthcare Innovation Award

Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

University of Washington, United States

Dr. Seo-Eun Choi is a distinguished Senior Research Scientist at the University of Washington, specializing in statistical applications in biomedical research, particularly Alzheimer’s disease and cognitive studies. She holds a Ph.D. in Statistics from Florida State University, an M.S. in Statistics from the University of Michigan – Ann Arbor, and a B.S. in Statistics with a minor in Computer Science from Ewha Womans University, South Korea. Over her career, Dr. Choi has developed deep expertise in Bayesian modeling, model selection, categorical and multivariate data analysis, spatio-temporal modeling, psychometrics, and neuroimaging data analysis. She has led and contributed to numerous international and interdisciplinary research projects, producing a strong publication record of 96 documents with 728 citations and an h-index of 12, highlighting her influence in both statistical methodology and clinical applications. Her research skills include advanced statistical computing, data visualization, and application of complex statistical models to large-scale neuroimaging and clinical datasets. Dr. Choi is an active member of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the American Statistical Association (ASA), reflecting her engagement with the broader scientific community and commitment to advancing collaborative research initiatives. Her contributions have been recognized through multiple awards and honors for excellence in statistical research, interdisciplinary collaboration, and mentorship, demonstrating her leadership and impact on the field. Looking forward, Dr. Choi’s work has significant potential to advance high-impact publications in Q1 journals, expand global collaborations, and provide mentorship to emerging researchers, thereby influencing both methodological innovation and practical applications in neurodegenerative disease research. Her combination of expertise, experience, and dedication makes her an exemplary candidate for recognition, reflecting outstanding contributions to science, research leadership, and societal impact in the field of biostatistics and neuroscience.

Profile: Google Scholar

Featured Publications

  1. Jutten, R. J., Grandoit, E., Foldi, N. S., Sikkes, S. A. M., Jones, R. N., Choi, S. E., … et al. (2020). Lower practice effects as a marker of cognitive performance and dementia risk: A literature review. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 12(1), 1–12.

  2. Mukherjee, S., Mez, J., Trittschuh, E. H., Saykin, A. J., Gibbons, L. E., Fardo, D. W., … et al. (2020). Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups. Molecular Psychiatry, 25(11), 2942–2951.

  3. Choi, S. E., Mukherjee, S., Gibbons, L. E., Sanders, R. E., Jones, R. N., Tommet, D., … et al. (2020). Development and validation of language and visuospatial composite scores in ADNI. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 6(1), e12024.

  4. Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., … et al. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554.

  5. Mukherjee, S., Choi, S. E., Lee, M. L., Scollard, P., Trittschuh, E. H., Mez, J., … et al. (2020). Cognitive domain harmonization and co-calibration in studies of older adults. Neuropsychology, 37(4), 409–423.

Lei Li | Biomedical Engineering | Best Researcher Award

Published on by WSA Awards

Prof. Lei Li | Biomedical engineering | Best Researcher Award

Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, China

Prof. Lei Li is a distinguished researcher in biomedical engineering, currently serving as Professor at the Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China. He earned his Ph.D. in Biomedical Engineering from Tsinghua University in 2009, after completing a B.S. in Thermal Engineering at the same institution. His professional experience spans over 15 years, including roles as Assistant Professor (2012–2019), Associate Professor (2019–2024), and Professor (2024–present) at the Chinese Academy of Sciences, with international exposure as a Visiting Scholar at Massachusetts General Hospital, Harvard University (2015–2016) and a Research Associate at WPI Advanced Institute for Materials Research, Tohoku University (2010). Professor Li’s research focuses on liquid metal biomaterials, lab-on-a-chip systems for cell research, and biomedical microsystems, with expertise in developing flexible wireless stimulators, magnetically responsive 3D scaffolds, electromagnetic wave shielding films, and microfluidic chips for cell culture and drug screening. He possesses advanced research skills in nanofabrication, microfluidics, biomedical device development, and lab-on-a-chip technology, demonstrated through 39 publications with 936 citations and an h-index of 18, featured in leading journals including Advanced Functional Materials, Science China-Materials, Carbon, Biosensors and Bioelectronics, and International Journal of Biological Macromolecules. Professor Li has contributed to books and chapters in nanobiotechnology, supervised numerous students, and actively engages in mentorship and collaborative research projects internationally. His professional excellence is recognized through multiple awards and honors in the field of biomedical engineering and materials science. With a strong track record in innovation, leadership, and research impact, Professor Li continues to advance global biomedical research, with significant potential to expand high-impact publications, foster international collaborations, participate in keynote lectures, and guide the next generation of researchers, solidifying his role as a leading figure in biomedical microsystems and liquid metal biomaterials research.

Profile: Scopus

Featured Publications

  1. Hydrophilic hard-magnetic soft robots: A new approach for precise droplet manipulation. (2025). Nanotechnology and Precision Engineering.

  2. Purified adipose tissue-derived extracellular vesicles facilitate adipose organoid vascularization through coordinating adipogenesis and angiogenesis. (2025). Biofabrication.

  3. A biomimetic magnetically responsive scaffold with tunable and stable compression for dynamic 3D cell culture. (2025). Science China Materials.

Ankit Agrawal | Health Professions | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Ankit Agrawal | Health Professions | Best Researcher Award

Post Graduate Institute of Child Health, India

Assist. Prof. Dr. Ankit Agrawal is an accomplished clinician and researcher in Pediatric Gastroenterology and Hepatology with a distinguished academic and professional trajectory marked by consistent excellence and leadership. He completed his MBBS at Peoples College of Medical Science and Research Centre, Bhopal, followed by an MD in Pediatrics  from Gajra-Raja Medical College, Gwalior, and a DM in Pediatric Gastroenterology from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow. He began his academic career as Assistant Professor at SGPGIMS and is currently serving as Assistant Professor in the Department of Pediatric Gastroenterology at Post Graduate Institute of Child Health, Delhi-NCR, Noida, where he integrates patient care, teaching, and research. His research interests encompass chronic pancreatitis, portal hypertension, pediatric liver diseases, and sustainable innovations in pediatric endoscopy, with a growing body of publications in reputed journals such as Pancreatology, Journal of Clinical and Experimental Hepatology, and Clinical and Experimental Pediatrics, along with contributions to academic books and clinical guidelines. Dr. Agrawal has developed extensive research skills in pediatric endoscopy, including diagnostic UGI endoscopy, colonoscopy, endoscopic band ligation, sclerotherapy, dilatations, polypectomy, and advanced interventional procedures, complemented by training in pediatric hepatology, metabolic liver diseases, and radiological interventions. His academic record includes 111 research documents, 402 citations, and an h-index of 10, reflecting his increasing impact in the field. Recognized internationally, he has received awards such as the First Prize for Best Poster at the Indian Society of Gastroenterology (ISG) Annual Conference (Jaipur, 2023) and the Young Investigator Award for oral presentations at the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN, Milan, 2024) and ISG Annual Conference (Varanasi, 2024). With strong professional expertise, collaborative research experience, and a commitment to child health, Dr. Agrawal exemplifies excellence in both academia and clinical practice. His future research and leadership potential lie in advancing global collaborations, increasing high-impact publications, and developing innovative approaches that elevate pediatric gastroenterology standards worldwide, making him highly deserving of recognition for his contributions to research and society.

Profile: Scopus

Featured Publications

Agrawal, A., Gaur, A., & Ambey, R. (2020). Neonatal mid upper arm circumference as surrogate of birth weight. International Journal of Contemporary Pediatrics, 7(3), 491–494.

Agrawal, A., Gaur, A., & Ambey, R. (2020). Newborn mid-upper arm circumference as valid proxy marker of gestational age. Indian Journal of Child Health, 7(2), 54–56.

Agrawal, A. (2024). Urgent need for “green endoscopy” in routine practice in India. Annals of Pediatric Gastroenterology and Hepatology (ISPGHAN).

Agrawal, A., Srivastava, A., Mishra, P., Malik, R., Agrawal, V., Raj, A., Sarma, M. S., Poddar, U., & Bhat, N. K. (2024). Quality of life is impaired in children with chronic pancreatitis: A multicenter study. Pancreatology, 24(6), 817–826.

Agrawal, A., & Sen Sarma, M. (2025). Vomiting: Causes, approach, and cyclical vomiting. In I. Gupta (Ed.), Learning through MCQ in Pediatrics. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd.

Agrawal, A., Srivastava, A., Moirangthem, A., Singh, S. M., Kodethoor, D., Vadlapudi, S. S., Sarma, M. S., & Poddar, U. (2025). Glycerol-3-Phosphate dehydrogenase 1 deficiency and steatotic liver disease in children: Our cases and review of literature. Journal of Clinical and Experimental Hepatology, 15(3), 102484.

Agrawal, A. (2025). Drugs in pediatric gastroenterology. Annals of Pediatric Gastroenterology and Hepatology, 6(4).

Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Published on by WSA Awards

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

Ismaeil Haririan | Pharmaceutical Biomaterials | Outstanding Scientist Award

Published on by WSA Awards

Prof. Ismaeil Haririan | Pharmaceutical Biomaterials | Outstanding Scientist Award

Teharn University of Medical Sciences (TUMS), Iran

Prof. Ismaeil Haririan is a distinguished Professor of Pharmaceutics and Pharmaceutical Biomaterials at the Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), where he also serves as the Founder of the Department of Pharmaceutical Biomaterials and Head of the Biomaterials Research Center. He earned his Pharm.D. from Tabriz University and pursued a Ph.D. in Pharmaceutics at the University of London in 1993, followed by postdoctoral research in targeted drug delivery, which laid the foundation for his lifelong contributions to biomaterials and regenerative medicine. With over three decades of academic and research experience, Prof. Haririan has played a pioneering role in advancing interdisciplinary research that integrates pharmacy, materials science, and biomedical engineering. His research interests span the design of hyaluronic acid hydrogels for bone and cartilage regeneration, 3D pharming and bioprinting, microfluidics in pharmaceutical applications, drug delivery systems, nanomedicine, and pharmaceutical rheology. He has authored more than 120 SCI-indexed articles, earning over 3,600 citations, an h-index of 34, and an i10-index of 65, reflecting the global impact of his work. His research skills extend across tissue engineering, drug delivery system design, nanostructure characterization, and translational medicine, complemented by his strong expertise in mentoring doctoral candidates and industrial trainees. Recognized internationally as a leading figure in pharmaceutical biomaterials, Prof. Haririan has received numerous awards and honors, including recognition as a world leader in bioprinting research between 2022 and 2025. Beyond his scholarly contributions, he has served in editorial capacities, led major research collaborations, and advanced education by supervising Pharm.D. and Ph.D. students. In conclusion, Prof. Haririan embodies academic excellence, visionary leadership, and innovative research, making him one of the most influential scientists in pharmaceutics and biomaterials whose work continues to inspire progress in regenerative medicine and pharmaceutical sciences worldwide.

Profile: Scopus | ORCID

Featured Publications

Al-Jawadri, A. M. H., Karami, Z., Haririan, I., Akrami, M., & Gholami, M. (2025). Development of a bio-inspired phagocytic stable nanoghost with anti-inflammatory properties for management of inflammation in ulcerative colitis. Journal of Drug Targeting, 33(7), 1-15.

Safari, F., Goudarzi, A., Abolghasemi, H., Mohammad, H. A., Akrami, M., Mohammadi, S., & Haririan, I. (2025). Additive manufacturing of regorafenib tablets: Formulation strategies and characterization for colorectal cancer. Polymers, 17(17), 2302.

Sohrabi, R., Miri, A. H., Rad-Malekshahi, M., Saadatpour, F., Pourjabbar, B., Keshel, S. H., Arefian, E., Balalaei, S., Masoumi, A., Khalili, F., Haririan, I., Akrami, M., & Shahriari, M. H. (2025). Corrigendum to “Development of silk fibroin/collagen film containing GI-20 peptide-loaded PLGA nanoparticles against corneal herpes simplex virus-1” [International Journal of Pharmaceutics, 669 (2025), 125022]. International Journal of Pharmaceutics, 674, 125369.

Torabi, M., Haririan, I., Foroumadi, A., Ghanbari, H., & Ghasemi, F. (2024). A deep learning model based on the BERT pre-trained model to predict the antiproliferative activity of anti-cancer chemical compounds. SAR and QSAR in Environmental Research, 35(11), 971-992

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Medical Director from Exeltis Healthcare | Germany 

Dr. Pedro Antonio Regidor is a dual-national (Spanish and German) medical doctor and scientist with over three decades of clinical and leadership experience in the field of gynecology and obstetrics. He is currently the Medical Director of Exeltis Europe & Global Projects, overseeing pharmaceutical initiatives and innovations in women’s health across international markets. Dr. Regidor is a specialist in gynecological oncology, reproductive medicine, surgical gynecology, and perinatal care, and has performed thousands of complex surgeries and deliveries. His clinical expertise is reinforced by his academic contributions, having earned an MD in 1992 and a PhD in 2000 from the University of Essen. He has held several key roles in prominent German institutions such as the University of Essen, Westfälische Wilhelms-Universität Münster, and Klinikum Osnabrück. In addition, he has served in leadership roles within private medical consultancies and pharmaceutical companies. Dr. Regidor’s career reflects a dynamic integration of patient care, medical research, academic excellence, and corporate strategy. Through his work with Exeltis and affiliations with multiple scientific boards, he continues to shape the future of gynecological healthcare and pharmaceutical development on a global scale.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Regidor’s academic foundation is built on a robust medical and scientific education acquired in Germany. He earned his Doctor of Medicine (MD) on 21 March 1992, with a thesis focused on immunohistochemical detection of progesterone receptors in various tissues. His pursuit of advanced knowledge continued with a PhD in Gynecology and Obstetrics awarded by the University of Essen on 14 April 2000, based on research into peritoneal endometriosis. His studies not only demonstrated academic excellence but also provided the groundwork for his specializations in women’s health. Throughout his educational journey, he gained comprehensive training in multiple sub-disciplines, including endocrine disorders, surgical gynecology, and diagnostic imaging techniques such as mammography and hysterosalpingography. Dr. Regidor also pursued professional licensure in multiple countries, including Germany and Switzerland, reflecting his global perspective and adaptability in medical practice. He earned several professional qualifications between 1995 and 2006, officially recognized as a specialist in gynecology and obstetrics, gynecological endocrinology, reproductive medicine, and gynecological oncology. His academic credentials have empowered him to lead not only in clinical settings but also in the pharmaceutical and medical research sectors, demonstrating a lifelong commitment to education and advancement in medical science.

Professional Experience

Dr. Pedro Antonio Regidor has accumulated over 30 years of diverse professional experience, ranging from university hospitals and private clinics to high-level executive roles in the pharmaceutical industry. He began his medical career as a junior and medical resident at the University of Essen, focusing on gynecological oncology. His international exposure included a residency at Clínica Maternidad Concepción Palacios in Caracas, Venezuela, which enriched his global medical perspective. He later served as Assistant Medical Director in Essen and at Westfälische Wilhelms-Universität Münster, eventually becoming Chief of the Department of Gynecology and Obstetrics at Klinikum Osnabrück. Following years of leading hospital-based services, Dr. Regidor transitioned into private consultancy and pharmaceutical leadership roles. Since 2009, he has been affiliated with Frauenklinik München West and worked in executive medical roles for Velvian Germany GmbH and Exeltis. Currently, he is Medical Director of Exeltis Europe & Global Projects, managing international clinical and product development strategies. His career is distinguished by thousands of complex surgeries, strategic oversight of medical centers, and leadership in multinational pharmaceutical operations. His ability to bridge clinical knowledge with organizational leadership makes him a rare expert in both hands-on patient care and large-scale medical innovation.

Research Interests

Dr. Regidor’s research interests lie primarily in gynecological oncology, reproductive medicine, endocrinology, and women’s health diagnostics and therapeutics. He has a strong academic inclination toward understanding the pathophysiology of endometriosis, as evidenced by his PhD research on immunohistochemical investigations. He is particularly focused on the integration of clinical evidence with pharmacological innovation, developing solutions that address unmet needs in hormone replacement therapy, fertility regulation, and perinatal management. Through his leadership at Exeltis, he also explores new formulations of estrogen and progesterone therapies, especially in menopausal care and contraceptive technologies. Dr. Regidor is deeply invested in the development and validation of clinical protocols for surgical interventions, breast reconstruction, hormone diagnostics, and cancer therapy. He continues to engage in international collaborative research projects, particularly in clinical trials involving women’s hormone treatments and breast cancer. Additionally, he serves on scientific boards and advisory committees that drive research agendas in reproductive endocrinology and gynecological oncology. His work frequently intersects clinical application with scientific innovation, making him a key figure in translational medicine.

Research Skills

Dr. Regidor possesses a highly specialized skill set that encompasses both clinical research and surgical expertise. He is proficient in conducting immunohistochemical analyses, clinical trial coordination, and protocol development. His strong foundation in gynecological diagnostics allows him to interpret laboratory results with precision and apply them directly in surgical and medical decision-making. His surgical record is extensive, with over 7,000 procedures ranging from total laparoscopic hysterectomies to breast reconstructions, demonstrating exceptional hands-on expertise. In research contexts, he is adept at designing clinical studies, interpreting biomedical data, and ensuring ethical compliance across international sites. He has a deep understanding of hormonal pathways, disease modeling, and advanced imaging techniques, including radiological diagnostics for gynecologic applications. Dr. Regidor is also skilled in multilingual communication, enabling him to effectively collaborate on global research initiatives. Furthermore, his involvement with pharmaceutical companies has honed his abilities in regulatory science, medical writing, and strategic development of therapeutic pipelines. His combined skills in surgery, diagnostics, and clinical research make him a versatile asset in both academic and industry settings.

Awards and Honors

Over the course of his distinguished career, Dr. Pedro-Antonio Regidor has received numerous appointments and recognitions reflective of his impact in gynecology and medical leadership. While his career is not defined by traditional academic awards, his leadership roles themselves signify recognition by his peers and institutions. He served as Coordinator and Founding Member of the Breast Center in Münster, a pioneering initiative that contributed to Germany’s breast cancer diagnostic network. His repeated appointments as Medical Director at Velvian Germany GmbH and Exeltis Germany, Europe, and Global Projects further underscore his reputation as a trusted leader in the medical and pharmaceutical sectors. Additionally, he has been entrusted with consultancy roles for companies like Lipocine Inc. (USA) in the field of hormone therapy, showcasing global acknowledgment of his expertise. He holds membership in over ten professional societies, including the German Society for Gynecology and Obstetrics, West German Tumor Center, and scientific advisory boards related to endometriosis and reconstructive surgery. These positions not only validate his contributions but also recognize his ability to drive forward scientific agendas with clinical relevance.

Publications Top Notes

  • Effect over coagulation and fibrinolysis parameters of a prolonged-release contraceptive (2025) – Gynecological Endocrinology – 1 citation.

  • Prevalence of cumulative cardiovascular risk factors among French women of childbearing age: GYNRISK® survey (2025) – Journal of Gynecology Obstetrics and Human Reproduction – 1 citation.

  • Randomised trial comparing bleeding profiles of prolonged vs immediate-release contraceptives (2025) – European Journal of Contraception and Reproductive Health Care – 3 citations.

  • Anti-inflammatory effects of marine oil enriched with SPMs in Post-COVID Syndrome patients (2024) – Biomedicines – 4 citations.

  • Marine oil supplements during pregnancy to prevent preterm delivery (Review).

  • Omega-3 fatty acids and their role in pregnancy complications like preeclampsia and chorioamnionitis (Review)

Conclusion

Dr. Pedro-Antonio Regidor stands out as a multifaceted leader in gynecology, medical research, and pharmaceutical innovation. His extensive clinical experience, combined with a strong academic foundation and strategic leadership in the pharmaceutical industry, positions him uniquely at the intersection of science and healthcare delivery. He has made significant contributions to women’s health through his pioneering surgical interventions, research in reproductive medicine, and development of hormone-based therapies. His roles in clinical practice, academia, and corporate governance reflect a deep commitment to advancing medical science and improving patient care. Dr. Regidor’s work has positively impacted thousands of patients and influenced the direction of therapeutic innovation across Europe and beyond. With ongoing involvement in global projects and advisory boards, he is poised to further shape the landscape of gynecological healthcare and translational research. His career exemplifies excellence, leadership, and a tireless pursuit of medical advancement, making him a highly deserving candidate for recognition in international research and medical awards.

Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Physical Therapy from Isfahan University of Medical Sciences, Iran

Dr. Tayebeh Roghani is an accomplished Assistant Professor at the Department of Physiotherapy, Faculty of Rehabilitation Sciences, Isfahan University of Medical Sciences, Iran. With over a decade of academic, clinical, and research experience, she has made significant contributions to the field of physiotherapy, especially in the areas of musculoskeletal aging and osteoporosis. Her career has been driven by a deep commitment to improving physical health outcomes for aging populations through evidence-based physiotherapeutic interventions. She has authored numerous peer-reviewed articles, systematic reviews, and book translations. Her scholarly contributions focus primarily on hyperkyphosis, balance, gait, postural control, and back muscle function, with a particular emphasis on older women. Dr. Roghani is also actively engaged in mentoring MSc students and supervising academic research projects, further demonstrating her role in fostering the next generation of rehabilitation scientists. She has participated in local and international congresses, presented both oral and poster presentations, and has acted as a peer reviewer for prestigious scientific journals. Her academic rigor, research productivity, and teaching excellence make her a standout in her field, and she is widely respected for her methodological approach to research and dedication to the advancement of physiotherapy education and practice.

Professional Profile

Education

Dr. Roghani began her academic journey in 2003 at Isfahan University of Medical Sciences, where she earned her Bachelor of Science (B.S) in Physiotherapy in 2007. Building on her foundational knowledge, she pursued her Master of Science (M.Sc.) in Physiotherapy at Tarbiat Modares University, Tehran, from 2008 to 2011. Her graduate research deepened her understanding of therapeutic methods and patient rehabilitation. She later advanced her academic qualifications by obtaining a Ph.D. in Physiotherapy from Shahid Beheshti University of Medical Sciences, Tehran, in 2017. Her doctoral work primarily investigated osteoporosis, aging-related hyperkyphosis, and associated motor control disorders in postmenopausal women. Throughout her academic training, she participated in numerous workshops and specialized courses, including ISI paper writing, systematic reviews, SPSS data analysis, and neurorehabilitation techniques. These academic milestones have equipped her with robust research capabilities and a strong theoretical foundation. Her progressive academic path, from undergraduate to doctoral studies, highlights her sustained commitment to advancing the scientific understanding of physiotherapy and promoting improved clinical interventions. Dr. Roghani’s education is not only comprehensive but also strategically aligned with her research interests and teaching roles, making her an influential academic figure in the rehabilitation sciences.

Professional Experience

Dr. Tayebeh Roghani has cultivated a distinguished professional career as a physiotherapist, academic, and researcher. Currently an Assistant Professor at Isfahan University of Medical Sciences (IUMS), she has played a key role in both clinical education and research supervision. Since 2014, she has taught numerous undergraduate and postgraduate courses, including hospital internships, therapeutic exercise, evidence-based physiotherapy, and electromyography. Her academic appointments span both Shahid Beheshti University of Medical Sciences and IUMS, reflecting her versatility and recognition across major institutions. Beyond teaching, she serves as an examiner for MSc proposals and theses, evaluating research on osteoarthritis, chronic pain, stroke rehabilitation, and more. Dr. Roghani has also contributed extensively to university-approved research projects focusing on back muscle function, hyperkyphosis, and menopause-related musculoskeletal changes. Her active role in departmental planning, curriculum development, and grand rounds further solidifies her academic leadership. Notably, she has reviewed scientific articles for reputed journals such as PLOS One and Osteoporosis International. Her professional trajectory reflects a blend of academic excellence, clinical insight, and research-driven innovation, positioning her as a leader in advancing rehabilitation practices and physiotherapy education in Iran and beyond.

Research Interest

Dr. Roghani’s primary research interests lie at the intersection of aging, musculoskeletal health, and physiotherapeutic intervention. Her research is focused on age-related hyperkyphosis, osteoporosis, motor control, and the physical functioning of older adults. She is particularly interested in understanding how spinal deformities and muscle imbalances influence postural stability, gait, and balance. Her work has extended into randomized controlled exercise trials to evaluate the effectiveness of aerobic and resistance training—both with and without external loading—on improving bone metabolism and physical fitness in postmenopausal women. Another significant area of her research is the assessment and enhancement of back extensor muscle function in individuals with age-related spinal curvature. She also investigates the clinical implications of musculoskeletal variables on abdominal bloating and gait speed in women experiencing menopause. Her approach is both experimental and evidence-based, often involving cross-sectional and comparative designs as well as systematic reviews and meta-analyses. Collaborating with both national and international researchers, she aims to translate clinical observations into scientifically validated treatment approaches. Her research not only adds depth to physiotherapy literature but also contributes to the development of effective, non-invasive interventions for aging populations.

Research Skills

Dr. Tayebeh Roghani brings a diverse set of research skills to the field of physiotherapy and rehabilitation sciences. Her proficiency includes designing and conducting randomized controlled trials, performing systematic reviews, and carrying out meta-analyses. She is well-versed in using statistical software such as SPSS for quantitative data analysis and has experience with MATLAB for modeling and simulation. Dr. Roghani is skilled in both clinical and experimental research methodologies, including biomechanical assessments, electromyography, and gait analysis. She has developed validated instruments to assess static back extensor strength and spinal curvature, enhancing reliability in clinical trials involving older women. Her understanding of hormonal biomarkers and their relationship to physical function adds a multidisciplinary edge to her research. She has also been trained in ethical research practices, data interpretation, and evidence-based protocol development. As a peer reviewer for international journals, she evaluates scientific manuscripts with a keen eye for methodological rigor and clarity. Dr. Roghani’s comprehensive research toolkit enables her to carry out robust investigations that bridge the gap between theory and clinical application, ultimately contributing to improved patient outcomes in musculoskeletal and geriatric rehabilitation.

Awards and Honors

Dr. Tayebeh Roghani has been the recipient of notable academic honors that recognize her commitment to excellence in physiotherapy education and research. During her doctoral studies, she was awarded the Ph.D. Student Distinguished Achievement Award in both the 9th and 10th Shahid Motahari Educational Festivals in 2014 and 2015 respectively. These prestigious awards are given to outstanding students who demonstrate exceptional academic performance, research quality, and educational leadership. The recognition reflects her strong dedication to physiotherapy as a scientific discipline and highlights her early contributions to the field, even before completing her Ph.D. Beyond these accolades, her selection as a peer reviewer for high-impact journals such as PLOS One, Osteoporosis International, and Physiotherapy Theory and Practice indicates professional recognition of her scholarly expertise. These honors, coupled with her institutional project approvals and invited academic roles, affirm her status as a leading academic and a role model within the field of rehabilitation sciences. Dr. Roghani’s career trajectory is marked not just by her achievements but by the consistent recognition of her excellence by peers, mentors, and academic institutions alike.

Conclusion

Dr. Tayebeh Roghani stands out as a dedicated and accomplished scholar whose contributions to the field of physiotherapy have had meaningful impact both in academia and clinical practice. With a strong educational foundation, impressive publication record, and a clear focus on aging-related musculoskeletal conditions, she brings depth, precision, and relevance to her research. Her ability to bridge theoretical knowledge with practical application positions her as a valuable asset in developing innovative rehabilitative approaches. Moreover, her role as a teacher, mentor, and examiner demonstrates her commitment to fostering the next generation of healthcare professionals. She is actively involved in collaborative research and maintains strong ties with institutional and international peers. While she has already achieved much, there remains significant potential for future growth through expanded global collaborations, grant acquisition, and continued interdisciplinary exploration. In summary, Dr. Roghani exemplifies the attributes of an outstanding researcher—rigorous, ethical, collaborative, and visionary. Her sustained efforts make her a highly suitable candidate for the Best Researcher Award, and her ongoing work promises continued advancements in rehabilitation science and physiotherapy for aging populations.

Publications Top Notes

  1. Comparison of Back Extensor Muscle Function in Older Males With and Without Age-Related Hyperkyphosis: A Protocol Study
    Journal: The Scientific Journal of Rehabilitation Medicine, 2025
    Authors: Anahita Vahdati, Hoda Niknam, Tayebeh Roghani

  2. Spinal‐Related Musculoskeletal Determinants of Functional Abdominal Bloating and Distension: A Narrative Review
    Journal: Health Science Reports, 2025
    DOI: 10.1002/hsr2.70976
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Amy Gladin, Wendy B. Katzman, Fateme Bokaee, Peyman Adibi

  3. Associations Between Menopause Status, Spinal-Related Musculoskeletal Variables and Gait Speed in Middle-Aged Females: A Short Report
    Journal: Musculoskeletal Care, 2024
    Authors: Faezeh Fatehi, Tayebeh Roghani, Azam Zafarbakhsh, Amy Gladin, Fateme Bokaee, Najimeh Tarkesh Isfahani, Ibrahim Abdollahpour, Hoda Niknam, Motahar Heidari-Beni, Wendy B. Katzman

  4. Comparison of Postural Balance, Muscle Force and Spinal Posture in Obese Children and Adolescents – A Protocol Study
    Journal: Iranian Journal of Diabetes and Obesity, 2024
    Authors: Fateme Reysy, Fateme Bokaee, Tayebeh Roghani, Grace O’Malley, Najimeh Tarkesh Esfahani, Motahar Heidari Beni, Roya Kelishadi

  5. Investigating the Difference Between Thoracic Kyphosis and Its Mobility in Community-Dwelling Older Men and Women
    Journal: Journal of Modern Rehabilitation, 2024
    Authors: Somayeh Mahmoodiaghdam, Maryam Nodehi, Himan Aryanfar, Tayebeh Roghani, Alireza Akbarzadeh Baghban, Minoo Khalkhali Zavieh

  6. Short and Medium-Term Effects of Kinesio Taping on Proprioception After Anterior Cruciate Ligament Reconstruction
    Journal: The Scientific Journal of Rehabilitation Medicine, 2024
    Authors: Tayebeh Roghani, Hoda Niknam, Mehdi Rezaei, Narges Jahantigh Akbari, Ali Asghar Jame Bozorgi

  7. The Association Between Physical Function and Hyperkyphosis in Older Females: A Systematic Review and Meta-Analysis
    Journal: Journal of Geriatric Physical Therapy, 2024
    Authors: Tayebeh Roghani, Diane D. Allen, Amy Gladin, Alireza Rahimi, Marziyeh Mehrabi, Zahra Sadat Rezaeian, Ziba Farajzadegan, Wendy B. Katzman

  8. The Comparison of Musculoskeletal Variables in Females With and Without Functional Abdominal Bloating: A Protocol Study
    Journal: Journal of Rehabilitation Sciences and Research, 2024
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Mostafa Raisi, Ibrahim Abdollahpour, Fateme Bokaee, Najimeh Tarkesh Isfahani, Seyed Mohsen Mirbod, Motahar Heidari-Beni, Peyman Adibi

Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Mr. Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Gansu Maternal and Child Health Care Hospital (Gansu Provincial Central Hospital), China

Dr. Juncheng Zhang is a highly experienced gynecologist with over 12 years of dedicated service in the field of obstetrics and gynecology. Currently serving as a Gynaecologist-in-charge, he has built a clinical and research career centered around women’s reproductive health, with a strong focus on cancer immunotherapy. His primary academic interest lies in the development of innovative immunotherapeutic treatments for cervical cancer, particularly adoptive cell therapy. Dr. Zhang has recently contributed to scholarly literature through a publication in the International Journal of Gynaecology & Obstetrics, underscoring his commitment to research-driven clinical advancements. Although his citation index and collaborations are still in development, his work presents significant potential for future impact in both academic and clinical communities. Dr. Zhang is recognized for his analytical thinking, patient-centered care, and efforts to bridge clinical practice with medical research. His self-motivation and commitment to continuous learning make him a valuable contributor to the medical field. With further opportunities for research collaborations and publication expansion, Dr. Zhang is on track to become a leading expert in immunotherapy for gynecological cancers. His emerging research profile demonstrates both promise and dedication to improving outcomes for patients affected by cervical cancer.

Professional Profile

Education

Dr. Juncheng Zhang’s educational foundation is rooted in medical science, with specialized training in obstetrics and gynecology. Although specific degree titles and institutions were not mentioned in his nomination form, it is clear that his qualifications have enabled him to serve as an attending physician in a clinical setting for over a decade. Typically, such a career trajectory involves earning a Bachelor of Medicine degree (MBBS or equivalent), followed by a residency or postgraduate specialization in gynecology and obstetrics. His academic background has equipped him with in-depth knowledge in both reproductive health and advanced medical interventions, particularly in the area of oncological gynecology. Dr. Zhang’s continued interest in research further reflects the academic rigor he has maintained throughout his professional development. The progression from medical training to research in immunotherapy suggests that he has received not only clinical training but also exposure to scientific research methodologies. As he continues to publish in indexed journals and engage in specialized research, it is likely that Dr. Zhang is either actively engaged in or planning to pursue further academic qualifications, such as a Master’s or Doctorate in a related field. This combination of clinical and research education forms a strong foundation for his contributions to women’s healthcare.

Professional Experience

Dr. Juncheng Zhang has amassed over 12 years of professional experience in the field of obstetrics and gynecology, currently holding the position of Gynaecologist-in-charge. His clinical responsibilities include managing women’s reproductive health, diagnosing and treating gynecological conditions, and performing both routine and complex procedures. Over the years, he has developed a profound understanding of the physiological and pathological aspects of gynecological diseases. In parallel to his clinical practice, Dr. Zhang has cultivated a strong research interest in cervical cancer, leading him to pursue scientific investigation alongside patient care. His dual role as a physician and a researcher has enabled him to directly translate clinical observations into research questions, fostering a pragmatic and relevant approach to medical research. His professional journey is marked by a transition into cancer immunotherapy, particularly the use of adoptive cell therapies, where he seeks to explore novel treatments for one of the most challenging diseases affecting women. Despite limited experience in industry consultancy or editorial roles, Dr. Zhang’s clinical leadership and emerging research credentials establish him as a dedicated and evolving professional in the medical community. His ongoing publication activity indicates a promising future trajectory, blending clinical excellence with research innovation.

Research Interests

Dr. Zhang’s primary research interests center on cervical cancer immunotherapy, a field that integrates immunology, oncology, and clinical medicine. He is particularly focused on adoptive cell therapy, which involves enhancing the body’s immune response by administering immune cells engineered or activated outside the body. This therapeutic strategy is gaining traction in cancer treatment and holds specific promise for cervical cancer, a disease with considerable global morbidity. His work on the role of CD3 and CD28 in cervical cancer cell proliferation and their impact on peripheral blood mononuclear cell (PBMC) invasion mechanisms reflects a molecular approach to understanding and combating cancer progression. Dr. Zhang aims to contribute to the scientific community by identifying innovative therapeutic pathways that improve treatment outcomes and reduce recurrence. His research bridges the gap between laboratory science and clinical application, contributing valuable knowledge to translational medicine. The use of tumor-infiltrating lymphocytes in treatment design is an especially promising avenue, and Dr. Zhang is actively exploring how this strategy can be tailored to individual patients. His focus aligns with international efforts to enhance targeted therapy and reduce treatment resistance in gynecologic oncology, and he is committed to advancing this research area through publication and potential clinical trials.

Research Skills

Dr. Juncheng Zhang demonstrates a strong command of essential research skills critical for biomedical innovation. His ability to design, execute, and analyze experiments involving immunotherapy mechanisms positions him as a competent translational researcher. He has practical experience in evaluating the roles of immune markers such as CD3 and CD28 in tumor biology, reflecting a solid grasp of molecular biology techniques. Dr. Zhang’s recent publication in an indexed journal illustrates his proficiency in scientific writing and literature synthesis. His knowledge of adoptive cell therapies further underscores familiarity with cutting-edge cancer treatment modalities and laboratory processes involved in cell preparation, expansion, and activation. Additionally, Dr. Zhang appears adept at hypothesis generation based on clinical challenges, a vital research skill that supports the development of impactful investigations. While his exposure to citation metrics and interdisciplinary collaborations may still be developing, the depth of his subject-specific expertise provides a strong foundation for future growth. As he continues to refine his research methodology and expand his publication record, Dr. Zhang is well-positioned to make significant contributions to the field of gynecologic oncology. His integrated skill set allows him to navigate both the clinical and research environments effectively, ensuring that his scientific work remains practically relevant.

Awards and Honors

While Dr. Juncheng Zhang has not listed specific awards or honors in his nomination form, his selection for consideration in the Best Researcher Award itself reflects growing recognition of his contributions to the field of cervical cancer immunotherapy. Emerging researchers often begin their award journey through peer-reviewed publications and conference presentations, milestones Dr. Zhang has started to achieve. His first major publication in a prestigious indexed journal suggests he is gaining visibility in the academic and clinical research communities. As his research matures and gains citation traction, opportunities for awards, fellowships, and research grants will likely follow. In many cases, clinician-researchers such as Dr. Zhang are recognized for bridging the gap between practice and innovation—a commendable achievement in itself. Awards in this domain typically follow impactful clinical trials, translational research breakthroughs, or innovations in patient care. With continued publication, collaborative projects, and deeper involvement in research societies, Dr. Zhang will be well-placed to receive formal honors from medical associations, academic institutions, and healthcare innovation platforms. His trajectory indicates strong potential for future awards as he builds upon his existing foundation of scientific and clinical excellence.

Conclusion

Dr. Juncheng Zhang is a promising clinician-researcher whose dedication to improving women’s healthcare through scientific innovation is clearly evident. With over a decade of experience as a gynecologist, he brings real-world clinical insights into the research laboratory, allowing for impactful, patient-centered investigation. His focused interest in cervical cancer immunotherapy, particularly in adoptive cell therapy, reflects a cutting-edge approach that aligns with global priorities in cancer research. Though his academic portfolio is still in its early stages, his first publication marks a critical step in establishing his presence in the research community. His methodological clarity, clinical depth, and strong motivation make him an ideal candidate for advanced recognition. While areas such as citation impact, professional society involvement, and collaboration are yet to be expanded, the foundations for a successful and influential research career are firmly in place. Continued publication, increased engagement in academic circles, and involvement in translational trials could significantly elevate his profile. In conclusion, Dr. Zhang is a valuable asset to the field of gynecologic oncology, and with the right opportunities and support, he has the potential to emerge as a leading figure in cancer immunotherapy research.

Publications Top Notes

  1. 🩺 Title: A rare case of pregnancy in a type II unicornuate uterus
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Hongfang Li

  2. 🦠 Title: A rare case of squamous cell carcinoma of the ovary
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Jianping Sun, Hongfang Li